James Lindsay

Professor of Inflammatory Bowel Disease.

Queen Mary University of London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

James Lindsay is a Professor of Inflammatory Bowel Disease at Queen Mary University of London, UK. His research areas include the effects of stress and medical treatments on inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, as well as the impact of ultra-processed foods on gut health. He is actively involved in developing innovative treatment protocols and evaluating biologics within the field of gastroenterology.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Jenny Byrne

Assoc prof of Haematology

University of Nottingham

UNITED KINGDOM

View details

Sreedhar Subramanian

UNITED KINGDOM

View details

Neil E. McCarthy

Queen Mary University of London

UNITED KINGDOM

View details

Ben Parker

Honorary Senior Lecturer

University of Manchester

UNITED KINGDOM

View details

Peter R. Gibson

AUSTRALIA

View details

Gordon Moran

University of Nottingham

UNITED KINGDOM

View details

Simon P L Travis

UNITED KINGDOM

View details

Kazuya Takahashi

Niigata University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

James Lindsay

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Developing an adaptive platform trial for evaluation of medical treatments for Crohn's disease.

Effects of Stress, Vagal Nerve Stimulation and Disease Activity on Circulating Cytokines, Quantified by an Ultrasensitive Technique, in Ulcerative Colitis: A Pilot Study

Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCT

Ultra-processed foods and food additives in gut health and disease

The incidence of remission and indicators of inadequate response to advanced therapy in patients with ulcerative colitis: results from medical charts in the United Kingdom

Establishment of a validated central reading system for ileocolonoscopy in an academic setting

The cation channel TRPM8 influences the differentiation and function of human monocytes

Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn's disease: A pilot study investigating the potential for primary prevention of inflammatory bowel disease

Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters.

Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab

Collaborators (8)

Jenny Byrne

Sreedhar Subramanian

Neil E. McCarthy

Ben Parker

Peter R. Gibson

Gordon Moran

Simon P L Travis

Kazuya Takahashi

Make your next move.